Patient advocacy groups, including those for Duchenne muscular dystrophy, issue a joint public statement opposing Overton's confirmation by 2026-10-28.
Posted 2026-09-28 — 30 days before the deadline, stated before the outcome.
The claim
Patient advocacy groups, including those for Duchenne muscular dystrophy, issue a joint public statement opposing Overton's confirmation by 2026-10-28.
Reasoning trace
- Patient's op-ed highlights Overton's perceived insensitivity
- Advocacy groups coordinate to amplify the message
- Joint statement opposing confirmation is released
Evidence so far
0 confirming · 0 denying signals · 1 verified · 0 broken assumptions. The evidence itself is part of the full dossier.
Probability history
Updated 1 time since mint (last on 2026-09-28) — 83% at mint → 81% today.
What to watch
- milestone The Muscular Dystrophy Association (MDA) publicly announces a coalition or joint effort with other patient advocacy groups to coordinate a response to Dr. Overton's nomination.
- leading indicator The MDA publishes a blog post, open letter, or social media post expressing concern about Dr. Overton's nomination or her previous statements.
- leading indicator The National Duchenne Alliance (NDA) publishes a public statement or blog post on its website criticizing Overton's suitability for the role.
The full dossier behind this prediction — the evidence trail, the risk analysis, the monetization scenarios — is available on request: [email protected].
Probabilities are calibrated against the system's own resolved history; after the deadline the outcome is resolved and audited — including the calls we get wrong. Nothing on this page is investment advice.